BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 15081896)

  • 1. Quantitative assessment of in vitro interactions implicates TATA-binding protein as a target of the VP16C transcriptional activation region.
    Nedialkov YA; Triezenberg SJ
    Arch Biochem Biophys; 2004 May; 425(1):77-86. PubMed ID: 15081896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The strength of acidic activation domains correlates with their affinity for both transcriptional and non-transcriptional proteins.
    Melcher K
    J Mol Biol; 2000 Sep; 301(5):1097-112. PubMed ID: 10966808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered promoter binding of the TATA box-binding factor induced by the transcriptional activation domain of VP16 and suppressed by TFIIA.
    Liljelund P; Ingles CJ; Greenblatt J
    Mol Gen Genet; 1993 Dec; 241(5-6):694-9. PubMed ID: 8264543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TFIIB-facilitated recruitment of preinitiation complexes by a TAF-independent mechanism.
    Hori RT; Xu S; Hu X; Pyo S
    Nucleic Acids Res; 2004; 32(13):3856-63. PubMed ID: 15272087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human general transcription factor TFIIB: conformational variability and interaction with VP16 activation domain.
    Hayashi F; Ishima R; Liu D; Tong KI; Kim S; Reinberg D; Bagby S; Ikura M
    Biochemistry; 1998 Jun; 37(22):7941-51. PubMed ID: 9609687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequence-dependent solution structure and motions of 13 TATA/TBP (TATA-box binding protein) complexes.
    Strahs D; Barash D; Qian X; Schlick T
    Biopolymers; 2003 Jun; 69(2):216-43. PubMed ID: 12767124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DA-complex assembly activity required for VP16C transcriptional activation.
    Kobayashi N; Horn PJ; Sullivan SM; Triezenberg SJ; Boyer TG; Berk AJ
    Mol Cell Biol; 1998 Jul; 18(7):4023-31. PubMed ID: 9632787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One-step affinity purification of recombinant TATA binding proteins utilizing a modular protein interaction partner.
    Shooltz DD; Alberts GL; Triezenberg SJ
    Protein Expr Purif; 2008 Jun; 59(2):297-301. PubMed ID: 18397834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural properties of the promiscuous VP16 activation domain.
    Jonker HR; Wechselberger RW; Boelens R; Folkers GE; Kaptein R
    Biochemistry; 2005 Jan; 44(3):827-39. PubMed ID: 15654739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural and functional characterization on the interaction of yeast TFIID subunit TAF1 with TATA-binding protein.
    Mal TK; Masutomi Y; Zheng L; Nakata Y; Ohta H; Nakatani Y; Kokubo T; Ikura M
    J Mol Biol; 2004 Jun; 339(4):681-93. PubMed ID: 15165843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional activation domain of the herpesvirus protein VP16 becomes conformationally constrained upon interaction with basal transcription factors.
    Shen F; Triezenberg SJ; Hensley P; Porter D; Knutson JR
    J Biol Chem; 1996 Mar; 271(9):4827-37. PubMed ID: 8617752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radical mutations reveal TATA-box binding protein surfaces required for activated transcription in vivo.
    Bryant GO; Martel LS; Burley SK; Berk AJ
    Genes Dev; 1996 Oct; 10(19):2491-504. PubMed ID: 8843200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-terminal transcriptional activation domain of LZIP comprises two LxxLL motifs and the host cell factor-1 binding motif.
    Luciano RL; Wilson AC
    Proc Natl Acad Sci U S A; 2000 Sep; 97(20):10757-62. PubMed ID: 10984507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chimeras of herpes simplex viral VP16 and jun are oncogenic.
    Schuur ER; Parker EJ; Vogt PK
    Cell Growth Differ; 1993 Sep; 4(9):761-8. PubMed ID: 8241024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMR structure of the complex between the Tfb1 subunit of TFIIH and the activation domain of VP16: structural similarities between VP16 and p53.
    Langlois C; Mas C; Di Lello P; Jenkins LM; Legault P; Omichinski JG
    J Am Chem Soc; 2008 Aug; 130(32):10596-604. PubMed ID: 18630911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of a DNA-bound transcriptional activator with the TBP-TFIIA-TFIIB-promoter quaternary complex.
    Dion V; Coulombe B
    J Biol Chem; 2003 Mar; 278(13):11495-501. PubMed ID: 12538582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protease footprinting reveals a surface on transcription factor TFIIB that serves as an interface for activators and coactivators.
    Hori R; Pyo S; Carey M
    Proc Natl Acad Sci U S A; 1995 Jun; 92(13):6047-51. PubMed ID: 7597078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Schizosaccharomyces pombe positive cofactor 4 stimulates basal transcription from TATA-containing and TATA-less promoters through Mediator and transcription factor IIA.
    Contreras-Levicoy J; Urbina F; Maldonado E
    FEBS J; 2008 Jun; 275(11):2873-83. PubMed ID: 18459978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRIC: Capturing the direct cellular targets of promoter-bound transcriptional activators.
    Dugan A; Pricer R; Katz M; Mapp AK
    Protein Sci; 2016 Aug; 25(8):1371-7. PubMed ID: 27213278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TFIIA changes the conformation of the DNA in TBP/TATA complexes and increases their kinetic stability.
    Hieb AR; Halsey WA; Betterton MD; Perkins TT; Kugel JF; Goodrich JA
    J Mol Biol; 2007 Sep; 372(3):619-32. PubMed ID: 17681538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.